» Articles » PMID: 25051140

Functional Evaluation of Key Interactions Evident in the Structure of the Eukaryotic Cys-loop Receptor GluCl

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2014 Jul 23
PMID 25051140
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The publication of the first high-resolution crystal structure of a eukaryotic Cys-loop receptor, GluClα, has provided valuable structural information on this important class of ligand-gated ion channels (LGIC). However, limited functional data exist for the GluCl receptors. Before applying the structural insights from GluCl to mammalian Cys-loop receptors such as nicotinic acetylcholine and GABA receptors, it is important to ensure that established functional features of mammalian Cys-loop receptors are present in the more distantly related GluCl receptors. Here, we seek to identify ligand-binding interactions that are generally associated with Cys-loop receptors, including the frequently observed cation-π interaction. Our studies were performed on the highly homologous GluClβ receptor, because GluClα is not activated by glutamate in Xenopus laevis oocytes. Mutagenesis of the signal peptide and pore lining helix was performed to enhance functional expression and sensitivity to applied ligand, respectively. Conventional and unnatural amino acid mutagenesis indicate a strong cation-π interaction between Y206 and the protonated amine of glutamate, as well as other important ionic and hydrogen bond interactions between the ligand and the binding site, consistent with the crystal structure.

Citing Articles

Association between the peripartum maternal and fetal telomere lengths and mitochondrial DNA copy numbers and preeclampsia: a prospective case-control study.

Zhang R, Du J, Xiao Z, Jiang Y, Jin L, Weng Q BMC Pregnancy Childbirth. 2022; 22(1):483.

PMID: 35698093 PMC: 9195426. DOI: 10.1186/s12884-022-04801-0.


Database of glutamate-gated chloride (GluCl) subunits across 125 nematode species: patterns of gene accretion and sequence diversification.

OHalloran D G3 (Bethesda). 2022; 12(2).

PMID: 35100348 PMC: 9210312. DOI: 10.1093/g3journal/jkab438.


Mutational Analysis at Intersubunit Interfaces of an Anionic Glutamate Receptor Reveals a Key Interaction Important for Channel Gating by Ivermectin.

Degani-Katzav N, Gortler R, Weissman M, Paas Y Front Mol Neurosci. 2017; 10:92.

PMID: 28428744 PMC: 5382172. DOI: 10.3389/fnmol.2017.00092.


Trapping of ivermectin by a pentameric ligand-gated ion channel upon open-to-closed isomerization.

Degani-Katzav N, Klein M, Har-Even M, Gortler R, Tobi R, Paas Y Sci Rep. 2017; 7:42481.

PMID: 28218274 PMC: 5317004. DOI: 10.1038/srep42481.


Unique Contributions of an Arginine Side Chain to Ligand Recognition in a Glutamate-gated Chloride Channel.

Lynagh T, Komnatnyy V, Pless S J Biol Chem. 2017; 292(9):3940-3946.

PMID: 28096462 PMC: 5339774. DOI: 10.1074/jbc.M116.772939.


References
1.
Frazier S, Cohen B, Lester H . An engineered glutamate-gated chloride (GluCl) channel for sensitive, consistent neuronal silencing by ivermectin. J Biol Chem. 2013; 288(29):21029-21042. PMC: 3774370. DOI: 10.1074/jbc.M112.423921. View

2.
Pons S, Sallette J, Bourgeois J, Taly A, Changeux J, Devillers-Thiery A . Critical role of the C-terminal segment in the maturation and export to the cell surface of the homopentameric alpha 7-5HT3A receptor. Eur J Neurosci. 2004; 20(8):2022-30. DOI: 10.1111/j.1460-9568.2004.03673.x. View

3.
Padgett C, Hanek A, Lester H, Dougherty D, Lummis S . Unnatural amino acid mutagenesis of the GABA(A) receptor binding site residues reveals a novel cation-pi interaction between GABA and beta 2Tyr97. J Neurosci. 2007; 27(4):886-92. PMC: 2649369. DOI: 10.1523/JNEUROSCI.4791-06.2007. View

4.
Lummis S, Beene D, Harrison N, Lester H, Dougherty D . A cation-pi binding interaction with a tyrosine in the binding site of the GABAC receptor. Chem Biol. 2005; 12(9):993-7. DOI: 10.1016/j.chembiol.2005.06.012. View

5.
Aziz M, Diallo S, Diop I, Lariviere M, Porta M . Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet. 1982; 2(8291):171-3. DOI: 10.1016/s0140-6736(82)91026-1. View